AzTrials
AzTrials

Cold Water ImmersionNCT06667479

Cold Water Exposure and Immune Function Study

A study testing Cold Water Immersion (CWI) - Cold Tub Immersion (CI) and Cold Water Immersion (CWI) - Cold Shower (CS) in people with Cold Water Immersion and Immune Function, run by University of Northern Colorado at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this clinical trial is to explore the effects of a 4 week cold-water immersion (CWI) intervention on measures of immune function, sleep quality, mental health and well-being, and muscular strength. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
What is being tested?
Cold Water Immersion (CWI) - Cold Tub Immersion (CI) and Cold Water Immersion (CWI) - Cold Shower (CS)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
37 participants
Where
1 siteUnited States
Study dates
10 Oct 2024to 1 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Males and Females
  • Aged 18-45

Who cannot join

  • Currently practices CWI for [\>3 times in the last month]
  • Pregnant or planning to become pregnant
  • Chronic use of anti-inflammatory medication
  • Prior history of chronic disease conditions:
  • Cardiovascular Disease
  • Diabetes
Show all 9Show fewer
  • Cancer
  • Raynaud\'s Disease
  • Severe and untreated anxiety or depression

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Northern Colorado - Gunter Hall

    Greeley, Colorado, 80631

Other trials in United States

About this study

Official title: Effects of a 4 Week Cold Tub vs Cold Shower Immersion Intervention on Immune Function, Sleep Quality, Mental Health and Well-being, Gut Health, and Muscular Strength in Healthy, Physically Active Adults

The purpose of this clinical trial is to explore the effects of a 4 week cold-water immersion (CWI) intervention on measures of immune function, sleep quality, mental health and well-being, and muscular strength. The main questions it aims to answer are:

  • Does a 4 week CWI intervention improve measures of immune function, sleep quality, mental health and well-being, and muscular strength?
  • Are there any differences in these measures when comparing cold tubs versus cold showers?
Read more

Researchers will compare chronic use of cold tubs to cold showers to see if cold water immersion may improve overall immune health and well-being. Participants will:

  • Undergo 4 weeks of Cold Tub or Cold Shower interventions at a frequency of 3 times a week for 4 minutes, if placed in the CWI intervention groups
  • Undergo testing measures at the two pre- and post- intervention time points, if placed in the healthy control group or the CWI intervention groups
Being tested
Cold Water Immersion (CWI) - Cold Tub Immersion (CI), Cold Water Immersion (CWI) - Cold Shower (CS), Control Group (CO)
Keywords
Cold Water Immersion, Cold Tub, Cold Shower, Immune Function, Mental Health, Muscular Strength, Healthy Adults, Inflammation, Gut Health
Medical subject headings
Psychological Well-Being, Inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cold Water Immersion (CWI) - Cold Tub Immersion (CI)Other

    Once thermoneutral procedures are complete, participants in the CI group will be seated in the cold tub and submerged into the water (10º C). The sternal notch of each participant will be used as the anatomical marker to mark submersion point. Participants will sit with both arms outstretched underwater with their backs not touching the sides of the tub. Participants with a shorter stature will be provided an underwater cushion to meet the submersion requirements. The 4-minute timer will begin once confirmation of the participants submersion level and posture is determined. Once completed, the participant will be instructed to slowly exit the tub and allowed to dry and change as necessary.

  • Cold Water Immersion (CWI) - Cold Shower (CS)Other

    Once thermoneutral procedures are complete, participants in the CS group will be instructed to enter the research shower area. Within the shower area, the walls of the shower will be numbered from 1 to 4, with 1 defined as facing the faucet, 2 defined as 90° to the right of side 1, 3 defined as 180° from the faucet, and 4 defined as 270° to the right or 90° C to the left from side 1. Participants will be instructed to turn 90° to the right cycling through sides 1 to 4 and then back to 1 every 15 seconds prompted by the researcher. This will allow the participant to complete four full rotations in the shower during the 4-minute intervention time. The shower faucet is modified and oriented in a way where it only produces cold water (10º C) when turned on. Once completed, the participant will be instructed to slowly exit the shower and is allowed to dry and change as necessary

  • Control Group (CO)Other

    Participants will be encouraged to maintain their current diet and exercise across the duration of the 4 week intervention. Participants will still be subjected to the pre- and post-intervention data collection session.

Study groups in NCT06667479
Study groupRoleWhat they receive
Cold Tub Immersion Group (CI)ExperimentalParticipants will utilize the research cold tub (10 ºC, 4-minutes, 3 times a week), following a standardized protocol (see intervention description).
Receives: Other: Cold Water Immersion (CWI) - Cold Tub Immersion (CI)
Cold Shower Group (CS)ExperimentalParticipants will utilize the research shower area (10 ºC, 4-minutes, 3 times a week), following a standardized protocol (see intervention description).
Receives: Other: Cold Water Immersion (CWI) - Cold Shower (CS)
Control Group (CO)OtherParticipants will not undergo any cold tub or cold shower intervention.
Receives: Other: Control Group (CO)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depression Anxiety and Stress Scales (DASS-21)

    Participants will be asked to complete a paper version of the 21-item Depression Anxiety and Stress Scale (DASS-21). The DASS-21 consists of 21 questions using a 0-3 Likert scale assessing the participant's subjective mental health and stress state with a "0" indicating "Did not apply to me at all" and "3" indicating "Applied to me very much or most of the time." The DASS-21 contains 3 sub scales assessing Depression, Anxiety, and Stress consisting of 7 questions for each sub scale, where a high score of 28+ indicates "Extremely Severe" levels of Depression, a high score of 20+ indicates "Extremely Severe" levels of Anxiety, and a high score of 34+ indicates "Extremely Severe" levels of Stress, while low scores of 0-9 indicates "Normal" levels of Depression, scores of 0-7 indicates "Normal" levels of Anxiety, and scores of 0-14 indicates "Normal" levels of Stress.

    Measured: Visit 1A (Week 1) and 2A (Week 4): 10 minutes each

  2. C-Reactive Protein

    Approximately 60mL of whole blood will be collected into serum separator tubes (Beckton Dickinson, East Rutherford, NJ, USA), allowed to clot for 30-min at room temperature, then centrifuged at 2000 RPM for 15 min. The serum will be pipetted into 1.5 mL microcentrifuge tubes (Eppendorf AG, Hamburg, Germany) and immediately stored in a -80 °C freezer. Serum concentrations of CRP will be determined with a commercially available enzyme-linked immunosorbent assay (ALPCO Diagnostics, Salem, NH, USA). Microplates will be read with an ELx800 BioTek microplate reader (BioTek Instruments, Inc., Winooski, VT, USA) at the recommended wavelength of 450 nanometers.

    Measured: Visit 1A (Week 1) and Visit 2A (Week 4): 15 minutes for blood draw. The assay itself takes 3 hours.

  3. Interleukin-6 (IL-6)

    Approximately 60mL of whole blood will be collected into serum separator tubes (Beckton Dickinson, East Rutherford, NJ, USA), allowed to clot for 30-min at room temperature, then centrifuged at 2000 RPM for 15 min. The serum will be pipetted into 1.5 mL microcentrifuge tubes (Eppendorf AG, Hamburg, Germany) and immediately stored in a -80 °C freezer. Serum concentrations of IL-6 will be determined with a commercially available enzyme-linked immunosorbent assay (Thermo Fisher Scientific, Waltham, MA, USA). Microplates will be read with an ELx800 BioTek microplate reader (BioTek Instruments, Inc., Winooski, VT, USA) at the recommended wavelength of 450 nanometers.

    Measured: Visit 1A (Week 1) and Visit 2A (Week 4): 15 minutes for blood draw. The assay itself takes 3 hours.

Secondary outcomes (2)
  1. Pittsburgh Sleep Quality Index (PSQI)

    Participants will be asked to complete a paper version of the Pittsburgh Sleep Quality Index (PSQI). The PSQI is a 19-question self-reported sleep quality tool broken up into 7 subcategories for scoring, such as subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. There are also 5 additional questions directed to the respondent's roommate or bed partner not used in the scoring, but utilized for clinical purposes.

    Measured: Visit 1A (Week 1) and 2A (Week 4): 10 minutes each

  2. Handgrip Dynamometry

    Isometric grip strength will be measured by a Baseline 12-0286 Electronic Smedly Hand Dynamometer (Fabrication Enterprises, White Plains, NY). To begin the test, participants will stand upright in a relaxed position; their upper extremity peak isometric grip strength will be assessed with the shoulder in 180º of flexion, elbow at full extension, and wrist and forearm in a neutral position. When prompted, participants will squeeze the device with their dominant hand, delivering a maximal effort for 3-seconds, followed by relaxation. After 30-seconds, the test will be run again. Three sets are completed for this test, and the highest value (kg) will be recorded for analysis.

    Measured: Visit 1B (Week 1) and Visit 2B (Week 4): 10 minutes each

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2024
  2. Study start10 Oct 2024
  3. Primary completion1 Feb 2026
  4. Study completion1 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallel, randomized design, matched for biological age
Masking
None (open label)
Enrolment
37 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06667479
Sponsor's protocol ID
2404058883
Status last verified
Nov 2025
First submitted
10 Oct 2024
Last updated
7 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All study documents will be made available upon reasonable request (Laura.stewart@unco.edu).

Questions about this trial

What is this clinical trial studying?

A study testing Cold Water Immersion (CWI) - Cold Tub Immersion (CI) and Cold Water Immersion (CWI) - Cold Shower (CS) in people with Cold Water Immersion and Immune Function, run by University of Northern Colorado at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depression Anxiety and Stress Scales (DASS-21) (time frame: Visit 1A (Week 1) and 2A (Week 4): 10 minutes each). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in